This inventor holds 3 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 424 
3 out of 12 Years Active: 2023-2025
Title: Atsushi Kanbayashi: Innovator in Pharmaceutical Formulations
Introduction
Atsushi Kanbayashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for enzalutamide. With a total of 3 patents, his work has implications for treating hyperproliferative disorders.
Latest Patents
Kanbayashi's latest patents focus on formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders. His innovative approach aims to enhance the efficacy of this important therapeutic agent.
Career Highlights
Throughout his career, Kanbayashi has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Medivation Prostate Therapeutics, Inc. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Some of his notable coworkers include Douglas Alan Lorenz and Sanjay Konagurthu. Their collaborative efforts have likely played a role in advancing the research and development of pharmaceutical innovations.
Conclusion
Atsushi Kanbayashi's contributions to the field of pharmaceutical formulations, particularly with enzalutamide, highlight his role as an innovator in the industry. His work continues to impact the treatment of hyperproliferative disorders, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile